BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19565661)

  • 1. Biocompatible nanoparticles trigger rapid bacteria clustering.
    Larsen MU; Seward M; Tripathi A; Shapley NC
    Biotechnol Prog; 2009; 25(4):1094-102. PubMed ID: 19565661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
    Liu Z; Jiao Y; Liu F; Zhang Z
    J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of nanoparticles formed by chitosan-caseinate interactions.
    Anal AK; Tobiassen A; Flanagan J; Singh H
    Colloids Surf B Biointerfaces; 2008 Jun; 64(1):104-10. PubMed ID: 18294821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of biocompatible nanoparticles via the self-assembly of chitosan and modified lecithin.
    Chuah AM; Kuroiwa T; Ichikawa S; Kobayashi I; Nakajima M
    J Food Sci; 2009; 74(1):N1-8. PubMed ID: 19200109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
    Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
    J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal cancer cell detection by 5-aminolaevulinic acid-loaded chitosan nano-particles.
    Yang SJ; Shieh MJ; Lin FH; Lou PJ; Peng CL; Wei MF; Yao CJ; Lai PS; Young TH
    Cancer Lett; 2009 Jan; 273(2):210-20. PubMed ID: 18809246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and characterization of amphotericin B-chitosan-dextran sulfate nanoparticles.
    Tiyaboonchai W; Limpeanchob N
    Int J Pharm; 2007 Feb; 329(1-2):142-9. PubMed ID: 17000065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-aggregation of water-soluble chitosan and solubilization of thymol as an antimicrobial agent.
    Hu Y; Du Y; Wang X; Feng T
    J Biomed Mater Res A; 2009 Sep; 90(3):874-81. PubMed ID: 18618589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmid size influences chitosan nanoparticle mediated gene transfer to chondrocytes.
    Xu X; Capito RM; Spector M
    J Biomed Mater Res A; 2008 Mar; 84(4):1038-48. PubMed ID: 17685397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization, and antimicrobial activity of quaternized chitosan/organic montmorillonite nanocomposites.
    Wang X; Du Y; Yang J; Tang Y; Luo J
    J Biomed Mater Res A; 2008 Feb; 84(2):384-90. PubMed ID: 17618481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of biopolymer-coated liposomes by electrostatic deposition of chitosan.
    Laye C; McClements DJ; Weiss J
    J Food Sci; 2008 Jun; 73(5):N7-15. PubMed ID: 18577008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan-mediated and spatially selective electrodeposition of nanoscale particles.
    Wu LQ; Lee K; Wang X; English DS; Losert W; Payne GF
    Langmuir; 2005 Apr; 21(8):3641-6. PubMed ID: 15807614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of aligned hematite nanoparticles on chitosan-alginate films.
    Sreeram KJ; Nidhin M; Nair BU
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):260-7. PubMed ID: 19303261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characterization of nanoparticles formed between DNA and phosphorylcholine substituted chitosans.
    Casé AH; Dalla Picola IP; Zaniquelli ME; Fernandes JC; Taboga SR; Winnik FM; Tiera MJ
    J Colloid Interface Sci; 2009 Aug; 336(1):125-33. PubMed ID: 19446829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex nanoparticles based on chitosan and ionic/nonionic strong polyanions: formation, stability, and application.
    Dragan ES; Mihai M; Schwarz S
    ACS Appl Mater Interfaces; 2009 Jun; 1(6):1231-40. PubMed ID: 20355918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles.
    Bravo-Osuna I; Ponchel G; Vauthier C
    Eur J Pharm Sci; 2007 Feb; 30(2):143-54. PubMed ID: 17157487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria.
    Kell AJ; Stewart G; Ryan S; Peytavi R; Boissinot M; Huletsky A; Bergeron MG; Simard B
    ACS Nano; 2008 Sep; 2(9):1777-88. PubMed ID: 19206416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin.
    Woitiski CB; Veiga F; Ribeiro A; Neufeld R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):25-33. PubMed ID: 19508892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
    Bravo-Osuna I; Vauthier C; Farabollini A; Palmieri GF; Ponchel G
    Biomaterials; 2007 Apr; 28(13):2233-43. PubMed ID: 17261330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antibacterial properties of a novel chitosan-Ag-nanoparticle composite.
    Sanpui P; Murugadoss A; Prasad PV; Ghosh SS; Chattopadhyay A
    Int J Food Microbiol; 2008 May; 124(2):142-6. PubMed ID: 18433906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.